Zentek Obtains Final Approval To List Equity On Nasdaq Global Market
Yet another Canadian firm is headed to the US big boards. Zentek Ltd (TSXV: ZEN) this morning revealed it has received final approval for listing its equity on the Nasdaq Capital Market. Formally known as Zen Graphene Solutions, the company initially submitted its listing application back in October.
In making the move to the big board, the company has indicated that it will continue to trade on the TSX Venture Exchange, in addition to the big board listing. The firm is expected to trade under the symbol “ZTEK” on the Nasdaq, with trading to commence within the next 60 days, although a final date was not provided.
The firm is said to be currently “evaluating market conditions” along with other considerations before selecting a date to commence trading.
Zentek bills itself as an IP development firm, whom is currently focused on commercializing its ZenGUARD product, a coating that has been demonstrated to have 99% antimicrobial activity. The product is said to be effective against COVID-19, and holds potential against other infectious diseases.
Zentek last traded at $3.27 on the TSX Venture.
Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
As the founder of The Deep Dive, Jay is focused on all aspects of the firm. This includes operations, as well as acting as the primary writer for The Deep Dive’s stock analysis. In addition to The Deep Dive, Jay performs freelance writing for a number of firms and has been published on Stockhouse.com and CannaInvestor Magazine among others.
